Amrize (AMRZ) Cash & Equivalents (2024 - 2026)

Amrize (AMRZ) has 3 years of Cash & Equivalents data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (changed N/A YoY), and the FY2025 full-year result was $1.9 billion, up 21.26% from the prior year.
• Cash & Equivalents fell to $1.1 billion in Q1 2026, from $1.9 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.9 billion in Q4 2025 to a low of $601.0 million in Q2 2025.
• A 3-year average of $1.2 billion and a median of $1.1 billion in 2026 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 21.26% in 2025, while the deepest fall reached 21.26% in 2025.
• Tracing AMRZ's Cash & Equivalents over 3 years: stood at $1.6 billion in 2024, then climbed by 21.26% to $1.9 billion in 2025, then sank by 42.82% to $1.1 billion in 2026.
• Business Quant data shows AMRZ's Cash & Equivalents at $1.1 billion in Q1 2026, $1.9 billion in Q4 2025, and $826.0 million in Q3 2025.